Duan H, Shi Q, Yue X, Zhang Z, Liu L, Wang Y
PLoS One. 2024; 19(12):e0303501.
PMID: 39642129
PMC: 11623562.
DOI: 10.1371/journal.pone.0303501.
Marty A, Bey C, Koenig K
One Health. 2024; 19:100927.
PMID: 39624159
PMC: 11609508.
DOI: 10.1016/j.onehlt.2024.100927.
Protopapas K, Dimopoulou D, Kalesis N, Akinosoglou K, Moschopoulos C
Viruses. 2024; 16(10).
PMID: 39459952
PMC: 11512351.
DOI: 10.3390/v16101620.
Satapathy P, Shamim M, Padhi B, Gandhi A, Sandeep M, Suvvari T
Commun Med (Lond). 2024; 4(1):188.
PMID: 39349678
PMC: 11443027.
DOI: 10.1038/s43856-024-00595-8.
Yu P, Elmor R, Muhammad K, Yu Y, Rao A
NEJM Evid. 2024; 3(10):EVIDoa2400189.
PMID: 39270215
PMC: 11421955.
DOI: 10.1056/EVIDoa2400189.
Mpox treatment evolution: past milestones, present advances, and future directions.
Ganesan A, Arunagiri T, Mani S, Kumaran V, Sk G, Elumalai S
Naunyn Schmiedebergs Arch Pharmacol. 2024; 398(2):1057-1080.
PMID: 39225831
DOI: 10.1007/s00210-024-03385-0.
Resolution of Stubborn Monkeypox With Tecovirimat in an HIV Patient.
Burstiner L, Rodriguez M, Guo H, Desai M, Agrawal A, Lam L
Cureus. 2024; 16(6):e63407.
PMID: 39077262
PMC: 11283921.
DOI: 10.7759/cureus.63407.
Understanding the biology of monkeypox virus to prevent future outbreaks.
Moss B
Nat Microbiol. 2024; 9(6):1408-1416.
PMID: 38724757
DOI: 10.1038/s41564-024-01690-1.
Expanded Access Programme for the use of tecovirimat for the treatment of monkeypox infection: A study protocol for an Expanded Access Programme.
Bourner J, Redji Mbrenga F, Malaka C, Dunning J, Rojek A, Fandema E
PLoS One. 2024; 19(5):e0278957.
PMID: 38722986
PMC: 11081255.
DOI: 10.1371/journal.pone.0278957.
Challenges in Managing Treatment-Resistant Mpox Complicated by Severe Superinfection.
Fortier J, Marsalisi C, Cordova E, Guo H, Verdecia J
Open Forum Infect Dis. 2024; 11(4):ofae138.
PMID: 38651138
PMC: 11034949.
DOI: 10.1093/ofid/ofae138.
Identifying potential monkeypox virus inhibitors: an study targeting the A42R protein.
Ashley C, Broni E, Wood C, Okuneye T, Ojukwu M, Dong Q
Front Cell Infect Microbiol. 2024; 14:1351737.
PMID: 38500508
PMC: 10945028.
DOI: 10.3389/fcimb.2024.1351737.
Association of Tecovirimat Therapy With Mpox Symptom Improvement: A Cross-sectional Study-King County, Washington, May-October 2022.
Karmarkar E, Golden M, Kerani R, Pogosjans S, Chow E, Bender Ignacio R
Open Forum Infect Dis. 2024; 11(3):ofae029.
PMID: 38456195
PMC: 10919389.
DOI: 10.1093/ofid/ofae029.
Clinical Features and Follow-Up of the First Two Cases of Mpox From Trinidad and Tobago.
Edwards R, Edwards J, Boyce G
Cureus. 2024; 16(1):e53149.
PMID: 38420056
PMC: 10900284.
DOI: 10.7759/cureus.53149.
[Human monkeypox (Mpox)].
Mrosik S, Rasokat H, Fabri M, Bopp L
Dermatologie (Heidelb). 2023; 75(1):40-47.
PMID: 38063873
DOI: 10.1007/s00105-023-05268-6.
A global systematic evidence review with meta-analysis of the epidemiological characteristics of the 2022 Mpox outbreaks.
Okoli G, Van Caeseele P, Askin N, Abou-Setta A
Infection. 2023; 52(3):901-921.
PMID: 38051425
DOI: 10.1007/s15010-023-02133-5.
Clinical Characteristics and Outcomes of Patients With Mpox Who Received Tecovirimat in a New York City Health System.
Vo C, Zomorodi R, Silvera R, Bartram L, Lugo L, Kojic E
Open Forum Infect Dis. 2023; 10(11):ofad552.
PMID: 38023539
PMC: 10644828.
DOI: 10.1093/ofid/ofad552.
Efficacy and safety of compassionate use for rare diseases: a scoping review from 1991 to 2022.
Wu J, Yang Y, Yu J, Qiao L, Zuo W, Zhang B
Orphanet J Rare Dis. 2023; 18(1):368.
PMID: 38017575
PMC: 10685565.
DOI: 10.1186/s13023-023-02978-x.
Acute Respiratory Distress Syndrome due to Monkeypox Virus.
Tchoubou T, El-Hosni R, Dollat M, Jaquet P, Tournus C, Tandjaoui-Lambiotte Y
Eur J Case Rep Intern Med. 2023; 10(11):004126.
PMID: 37920221
PMC: 10619529.
DOI: 10.12890/2023_004126.
Antivirals against Monkeypox (Mpox) in Humans: An Updated Narrative Review.
Bruno G, Buccoliero G
Life (Basel). 2023; 13(10).
PMID: 37895350
PMC: 10608433.
DOI: 10.3390/life13101969.
Mpox virus infection and drug treatment modelled in human skin organoids.
Li P, Pachis S, Xu G, Schraauwen R, Incitti R, de Vries A
Nat Microbiol. 2023; 8(11):2067-2079.
PMID: 37828248
DOI: 10.1038/s41564-023-01489-6.
